Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.

Aubert P, Suárez-Fariñas M, Mitsui H, Johnson-Huang LM, Harden JL, Pierson KC, Dolan JG, Novitskaya I, Coats I, Estes J, Cowen EW, Plass N, Lee CC, Sun HW, Lowes MA, Goldbach-Mansky R.

PLoS One. 2012;7(11):e49408. doi: 10.1371/journal.pone.0049408. Epub 2012 Nov 30.

2.

Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.

Goldbach-Mansky R.

Curr Rheumatol Rep. 2011 Apr;13(2):123-31. doi: 10.1007/s11926-011-0165-y. Review.

3.

Treating inflammation by blocking interleukin-1 in humans.

Dinarello CA, van der Meer JW.

Semin Immunol. 2013 Dec 15;25(6):469-84. doi: 10.1016/j.smim.2013.10.008. Epub 2013 Nov 23. Review.

4.

[CAPS treatment].

Jiménez Treviño S, Ramos Polo E.

Med Clin (Barc). 2011 Jan;136 Suppl 1:29-33. doi: 10.1016/S0025-7753(11)70006-9. Review. Spanish.

PMID:
21596184
5.

Anakinra for cryopyrin-associated periodic syndrome.

Koné-Paut I, Galeotti C.

Expert Rev Clin Immunol. 2014 Jan;10(1):7-18. doi: 10.1586/1744666X.2014.861325. Epub 2013 Nov 21. Review.

PMID:
24308832
6.

Rilonacept in the treatment of chronic inflammatory disorders.

McDermott MF.

Drugs Today (Barc). 2009 Jun;45(6):423-30. doi: 10.1358/dot.2009.45.6.1378935. Review.

PMID:
19649332
7.

An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases.

Pazyar N, Feily A, Yaghoobi R.

Curr Clin Pharmacol. 2012 Nov;7(4):271-5. Review.

PMID:
22794157
8.

Canakinumab for the treatment of cryopyrin-associated periodic syndromes.

Walsh GM.

Drugs Today (Barc). 2009 Oct;45(10):731-5. doi: 1396674/dot.2009.45.10.1416583. Review.

PMID:
20069137
9.

Cryopyrin-associated periodic syndromes and autoinflammation.

Shinkai K, McCalmont TH, Leslie KS.

Clin Exp Dermatol. 2008 Jan;33(1):1-9. Epub 2007 Oct 9. Review.

PMID:
17927785
11.

The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.

Satoh T, Otsuka A, Contassot E, French LE.

Immunotherapy. 2015;7(3):243-54. doi: 10.2217/imt.14.106. Review.

PMID:
25804477
12.

Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.

Ozkurede VU, Franchi L.

Clin Exp Immunol. 2012 Mar;167(3):382-90. doi: 10.1111/j.1365-2249.2011.04535.x. Review.

13.

Targeting interleukin-1β in CAPS (cryopyrin-associated periodic) syndromes: what did we learn?

Koné-Paut I, Piram M.

Autoimmun Rev. 2012 Nov;12(1):77-80. doi: 10.1016/j.autrev.2012.07.026. Epub 2012 Aug 2. Review.

PMID:
22884551
14.

Cryopyrin-associated periodic syndromes: diagnosis and management.

Miyamae T.

Paediatr Drugs. 2012 Apr 1;14(2):109-17. doi: 10.2165/11595040-000000000-00000. Review.

PMID:
22335455
15.

[An approach to the patients with cryopyrin-associated periodic syndrome (CAPS) : a new biologic response modifier, canakinumab].

Yokota S, Kikuchi M, Nozawa T, Kizawa T, Kanetaka T, Miyamae T, Mori MA, Nishikomori R, Takata H, Heike T, Hara T, Imagawa T.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(1):23-9. Review. Japanese.

16.

[Indications and modes of use for interleukin (IL)-1 antagonists in inflammatory dermatosis: a new therapeutic approach to immune-mediated inflammatory diseases].

Lipsker D, Lenormand C.

Ann Dermatol Venereol. 2012 Jun;139(6-7):459-67. doi: 10.1016/j.annder.2012.03.012. Epub 2012 Apr 17. Review. French.

PMID:
22721478
17.

[Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome].

Aróstegui JI.

Med Clin (Barc). 2011 Jan;136 Suppl 1:22-8. doi: 10.1016/S0025-7753(11)70005-7. Review. Spanish.

PMID:
21596183
18.

Cryopyrin-associated periodic syndrome: a case report and review of the Japanese literature.

Aoyama K, Amano H, Takaoka Y, Nishikomori R, Ishikawa O.

Acta Derm Venereol. 2012 Jul;92(4):395-8. doi: 10.2340/00015555-1322. Review.

19.

Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Goldbach-Mansky R, Kastner DL.

J Allergy Clin Immunol. 2009 Dec;124(6):1141-9; quiz 1150-1. doi: 10.1016/j.jaci.2009.11.016. Review.

20.

Lessons from interleukin-deficient mice: the interleukin-1 system.

Fantuzzi G.

Acta Physiol Scand. 2001 Sep;173(1):5-9. Review.

PMID:
11678721
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk